$1.18
0.04[3.51%]
At close: Apr 24
Arch Therapeutics
(OTCQB:ARTH)Arch Therapeutics Stock (OTC:ARTH), Analyst Ratings, Price Targets, Predictions
Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Analyst Ratings for Arch Therapeutics
No data available to display
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|
FAQ
What is the target price for Arch Therapeutics (ARTH)?
There is no price target for Arch Therapeutics.
What is the most recent analyst rating for Arch Therapeutics (ARTH)?
There is no analyst for Arch Therapeutics.
When was the last upgrade for Arch Therapeutics (ARTH)?
There is no last upgrade for Arch Therapeutics.
When was the last downgrade for Arch Therapeutics (ARTH)?
There is no last downgrade for Arch Therapeutics.
When is the next analyst rating going to be posted or updated for Arch Therapeutics (ARTH)?
There is no next analyst rating for Arch Therapeutics.
Is the Analyst Rating Arch Therapeutics (ARTH) correct?
There is no next analyst rating for Arch Therapeutics.
Browse analyst ratings and price targets on all stocks.